APA (7th ed.) Citation

Tsai, M., Chrones, L., Xie, J., Gevorkyan, H., & Macek, T. (2016). A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor. Psychopharmacology, 233(21/22), 3787. https://doi.org/10.1007/s00213-016-4412-9

Chicago Style (17th ed.) Citation

Tsai, Max, Lambros Chrones, Jinhui Xie, Hakop Gevorkyan, and Thomas Macek. "A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-063, a Selective PDE10A Inhibitor." Psychopharmacology 233, no. 21/22 (2016): 3787. https://doi.org/10.1007/s00213-016-4412-9.

MLA (9th ed.) Citation

Tsai, Max, et al. "A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-063, a Selective PDE10A Inhibitor." Psychopharmacology, vol. 233, no. 21/22, 2016, p. 3787, https://doi.org/10.1007/s00213-016-4412-9.